Moleculin Biotech Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC | 05/15/2026 | 75.02 K | $171.80 K | 100.00% | 0.18% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 32.33 K | $74.03 K | 113.56% | 0.08% |
| 05/15/2026 | 13.87 K | $31.76 K | 100.00% | 0.03% | |
| HRT FINANCIAL LP | 05/14/2026 | 13.74 K | $31.00 K | 100.00% | 0.03% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 6.07 K | $13.91 K | 100.00% | 0.01% |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | 05/14/2026 | 4.42 K | $10.12 K | 1,927.98% | 0.01% |
| UBS GROUP AG | 05/05/2026 | 3.41 K | $7.81 K | -41.86% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 1.84 K | $4.20 K | 31.73% | 0.00% |
| BLACKROCK, INC. | 05/13/2026 | 491 | $1.12 K | -0.81% | 0.00% |
| 05/15/2026 | 434 | $994 | 0.00% | 0.00% | |
| PINNACLE WEALTH PLANNING SERVICES, INC. | 05/11/2026 | 281 | $643 | 0.00% | 0.00% |
| NEWBRIDGE FINANCIAL SERVICES GROUP, INC. | 05/05/2026 | 114 | $261 | 0.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 04/28/2026 | 43 | $98 | 48.28% | 0.00% |
| MORGAN STANLEY | 05/15/2026 | 36 | $83 | 0.00% | 0.00% |
| VANGUARD GLOBAL ADVISERS, LLC | 05/08/2026 | 24 | $55 | 100.00% | 0.00% |
| FMR LLC | 05/15/2026 | 3 | $7 | 100.00% | 0.00% |
| DANSKE BANK A/S | 05/12/2026 | 2 | $5 | 0.00% | 0.00% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 05/11/2026 | 2 | $5 | 100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 05/15/2026 | 1 | $2 | 0.00% | 0.00% |
| CVA FAMILY OFFICE, LLC | 04/29/2026 | 1 | $2 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 05/12/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Moleculin Biotech Inc institutional Ownership - FAQ's
During the previous two years, 25 institutional investors and hedge funds held shares of Moleculin Biotech Inc. The most heavily invested institutionals were:
SABBY MANAGEMENT, LLC: 75,021
GEODE CAPITAL MANAGEMENT, LLC: 32,329
HRT FINANCIAL LP: 13,739
VANGUARD FIDUCIARY TRUST CO: 6,072
Rockefeller Capital Management L.P.: 4,421
UBS Group AG: 3,409
0.37% of Moleculin Biotech Inc stock is owned by institutional investors.
Institutional investors have bought a total of 166.27 K shares in the last 24 months. This purchase volume represents approximately $325.88 K in transactions.